Jewish Values Investors JLens Target Israeli Company
Teva stock drops 13% as Tel Aviv trade begins - Israel News - The Jerusalem Post
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva's Recovery Hopes Mired in Staggering Antitrust Lawsuit, $26.7 Billion Debt | The Jewish Press - JewishPress.com | David Israel | 7 Iyyar 5779 – May 12, 2019 | JewishPress.com
Jury holds drugmaker Teva liable in opioid crisis | KOKH
TEVA.TA - | Stock Price & Latest News | Reuters
Teva Stock: What We Know, And Don't, About The Adderall Shortage | Investor's Business Daily
Teva Pharmaceutical's Sales Slump 18% - WSJ
Teva Pharmaceutical Initiated at Market Perform at BMO - TheStreet
Teva's Stock Price Surge Against Its Predictable Woes
Teva CEO Rejects Netanyahu Plea to Salvage Jerusalem Plant - Bloomberg
Teva cedes spot as Israel's biggest firm in blow to prestige | Mint
Teva Sells Closed Factory, Land Rights in $30M Deal | The Jewish Press - JewishPress.com | Hana Levi Julian | 30 Shevat 5779 – February 4, 2019 | JewishPress.com
Teva joins the executive pay big leagues after doling out $17M to new CEO Kare Schultz | Fierce Pharma
U.S. approval of Teva drug could help reverse company's migraines - The Jerusalem Post
Israeli Teva reaches proposed $4.35 bln settlement of US opioid lawsuits - The Jerusalem Post
Teva Pharmaceuticals appoints Richard Francis CEO | HealthCare Middle East & Africa Magazine
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Israeli drugmaker Teva to cut quarter of global work force (Update)
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Israel-based Teva settles opioid lawsuit with San Francisco for $45M
24 Teva Stock Video Footage - 4K and HD Video Clips | Shutterstock
Teva stock downgraded to neutral by UBS on heels of $85 million opioid settlement - MarketWatch
